Summary

All participants will be randomly divided into 1mg DST group(Intervention group,n=43) and placebo group(Control group,n=43) and to determining the subtypes and to compare the long-term outcomes of patients with PA.

Study Name: Adrenal Venous Sampling Under 1 mg Overnight Dexamethasone Suppression Test to Determine Subtype in Primary Aldosteronism
Status: Recruiting
Conditions: Primary aldosteronism
Interventions: Drug: Dexamethasone 1 MG Oral Tablet, Drug: Placebo
Locations: Zhongshan Hospital, Fudan University, Shanghai, China
Study link: https://clinicaltrials.gov/ct2/show/NCT04709185

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.